These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature. Strunk H; Marinova M Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395 [TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunts in the management of Budd-Chiari syndrome in the liver transplant patient with intractable ascites: anatomic considerations. Richard HM; Cooper JM; Ahn J; Silberzweig JE; Emre SH; Mitty HA J Vasc Interv Radiol; 1998; 9(1 Pt 1):137-40. PubMed ID: 9468407 [No Abstract] [Full Text] [Related]
12. Evolving Indications for Tips. Smith M; Durham J Tech Vasc Interv Radiol; 2016 Mar; 19(1):36-41. PubMed ID: 26997087 [TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation. Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685 [TBL] [Abstract][Full Text] [Related]
14. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications. Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789 [TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Salerno F; Cammà C; Enea M; Rössle M; Wong F Gastroenterology; 2007 Sep; 133(3):825-34. PubMed ID: 17678653 [TBL] [Abstract][Full Text] [Related]
16. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites. Garcia-Tsao G Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501 [TBL] [Abstract][Full Text] [Related]
17. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients. He FL; Wang L; Yue ZD; Zhao HW; Liu FQ World J Gastroenterol; 2014 Sep; 20(33):11835-9. PubMed ID: 25206289 [TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunt following liver transplantation: can outcomes be predicted? El Atrache M; Abouljoud M; Sharma S; Abbass AA; Yoshida A; Kim D; Kazimi M; Moonka D; Brown K Clin Transplant; 2012; 26(4):657-61. PubMed ID: 22309034 [TBL] [Abstract][Full Text] [Related]